Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/16/2000WO2000068419A2 Apparatus and process for monitoring and detecting small molecule-biomolecule interactions
11/16/2000WO2000068418A1 Assays for nucleoside diphosphates and triphospates
11/16/2000WO2000068415A2 A method for measuring biomolecules
11/16/2000WO2000068411A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
11/16/2000WO2000068382A1 PrP-LIKE GENE
11/16/2000WO2000068381A1 Cytokine receptor mouse zcytor10
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068377A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000WO2000068373A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000WO2000068367A1 Assay reagent
11/16/2000WO2000068362A2 Undifferentiated erythroid cells and their use in ligand binding assays
11/16/2000WO2000068268A1 Human gabab receptor 1 promoters
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000068242A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000WO2000068185A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000WO2000067872A2 High throughput crystal form screening workstation and method of use
11/16/2000WO2000067804A1 Competitive chemiluminescent assay for cyclic nucleotide monophosphates
11/16/2000WO2000067803A1 Compositions and methods for improving learning and memory
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067785A2 Staphyloccocus aureus antigen-containing whole cell vaccine
11/16/2000WO2000067784A1 Bacteriophage isolated from bacterial genomes and extrachromosomal elements and methods of use thereof
11/16/2000WO2000067739A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
11/16/2000WO2000067737A2 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION
11/16/2000WO2000067736A2 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone
11/16/2000WO2000067735A2 USE OF SELECTIVE ANTAGONISTS OF THE α1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/16/2000WO2000067634A2 Airway-based cardiac output monitor and methods for using same
11/16/2000WO2000067568A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000WO2000067566A1 Method and apparatus for selectively classifying poultry eggs
11/16/2000WO2000058502A3 Use of collagenase 3 for detecting destructive diseases of the joints
11/16/2000WO2000046869A3 Method and device for quantitatively determining alcohols by means of fuel cells
11/16/2000WO2000046602A3 Method for determining the concentration of thrombin inhibitors
11/16/2000WO2000044876A3 Method, vessel and device for monitoring metabolic activity of cell cultures in liquid media
11/16/2000WO2000044273A3 Diagnosis and prediction of light therapy response in seasonal affect disorder patients using g-protein subunit measurements
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000039325A3 Affinity sensor for detecting specific molecular binding events and use thereof
11/16/2000WO2000039287A3 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
11/16/2000WO2000038536A3 Inhibitors of the bitter taste response
11/16/2000WO2000037613A3 Human akt-3
11/16/2000WO2000037025A3 Antibodies to truncated vegf-d and uses thereof
11/16/2000WO2000036396A3 Axial pattern analysis and sorting instrument for multicellular organisms employing improved light scatter trigger
11/16/2000WO2000033874B1 Boron neutron capture therapy using pre-targeting methods
11/16/2000WO2000032814A3 Methods for producing selected interstrand cross-links in nucleic acids and applications thereof
11/16/2000WO2000031536A3 Detecting structural or synthetic information about chemical compounds
11/16/2000WO2000031305A3 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026247A3 Ikaros isoforms and mutants
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000023621A3 Visualization of rna in living cells
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000009999A9 Information storage and transmittal for medical diagnostic devices
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000006525A3 Synthesis of combinatorial libraries of compounds reminiscent of natural products
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO1999058981A3 Diagnostic tests for alzheimer's disease
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000WO1999035491A3 Method for detecting growth and stress in plants and for monitoring textile fiber quality
11/16/2000DE19923074A1 Apparatus for imaging particles, e.g. cells or emulsion droplets, comprises a high-resolution video microscope with an electronic camera trained on a flash-illuminated agitated particle suspension
11/16/2000DE19921999A1 Continuous determination of concentration of organisms suspended in liquid is achieved by inference from a variation in parameters of one or more metabolites, using data acquisition system
11/16/2000DE19921234A1 New cyanine dyes useful as fluorescent labels for e.g. cells, antibodies, proteins, hormones, nucleic acids, oligonucleotides and carbohydrates, comprise sulfoaryl and N-sulfoalkyl groups and a carrier-binding reactive group
11/16/2000DE19920244A1 Determining the inhibiting effect of a waste water sample on microbial nitrification, using a preserved pure culture of a nitrifying bacterial strain as test organism
11/16/2000DE19919225A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/16/2000DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers
11/16/2000DE19908151A1 Manufacturing elements from concrete involves checking consistency of concrete during delivery and at point of manufacture by measuring moisture content and temperature of concrete
11/16/2000DE19907461C1 Instrumented, In-situ simulator, loosely resembling lysimeter and used for measurement of radon migration in ground, includes column of earth with upper and lower chambers for gas release and accumulation
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000CA2503110A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000CA2373873A1 Competitive chemiluminescent assay for cyclic nucleotide monophosphates
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373617A1 Compositions and methods for improving learning and memory
11/16/2000CA2373550A1 Methods of identifying therapeutic compounds in a genetically defined setting
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373348A1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
11/16/2000CA2373182A1 A structure-based approach to design inhibitors of protein-processivity factor interactions
11/16/2000CA2373150A1 Method for diagnosis of alzheimer's disease
11/16/2000CA2373146A1 A method of detecting an analyte using semiconductor nanocrystals
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372854A1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372735A1 Assay reagent
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372658A1 Airway-based cardiac output monitor and methods for using same
11/16/2000CA2372635A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000CA2372597A1 Human gabab receptor 1 promoters
11/16/2000CA2372515A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000CA2372157A1 Method and apparatus for selectively classifying poultry eggs
11/16/2000CA2371843A1 Multiple tag analysis
11/16/2000CA2371647A1 Method for anticipating, delaying and/or preventing the risk of spontaneous combustion and/or explosion of an explosive atmosphere
11/16/2000CA2371219A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities
11/16/2000CA2371195A1 Cells and assays
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000CA2369577A1 Method for detecting microorganisms in a sample
11/16/2000CA2368315A1 Apparatus and process for monitoring and detecting small molecule-biomolecule interactions